American Healthcare REIT, Inc. $AHR Shares Sold by Cwm LLC

Cwm LLC trimmed its position in American Healthcare REIT, Inc. (NYSE:AHR) by 0.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 180,362 shares of the company’s stock after selling 1,163 shares during the period. Cwm LLC owned approximately 0.11% of American Healthcare REIT worth $6,626,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Personalized Indexing Management LLC acquired a new stake in American Healthcare REIT in the second quarter worth approximately $282,000. Aberdeen Group plc lifted its position in American Healthcare REIT by 58.6% in the second quarter. Aberdeen Group plc now owns 1,337,748 shares of the company’s stock worth $49,149,000 after purchasing an additional 494,370 shares during the period. KLP Kapitalforvaltning AS lifted its position in American Healthcare REIT by 11.9% in the second quarter. KLP Kapitalforvaltning AS now owns 33,000 shares of the company’s stock worth $1,219,000 after purchasing an additional 3,500 shares during the period. Franchise Capital Ltd lifted its position in shares of American Healthcare REIT by 76.8% during the 2nd quarter. Franchise Capital Ltd now owns 4,375 shares of the company’s stock valued at $161,000 after acquiring an additional 1,900 shares during the last quarter. Finally, Knights of Columbus Asset Advisors LLC acquired a new stake in shares of American Healthcare REIT during the 2nd quarter valued at $3,832,000. 16.68% of the stock is currently owned by institutional investors and hedge funds.

American Healthcare REIT Trading Up 3.0%

NYSE AHR opened at $42.73 on Thursday. American Healthcare REIT, Inc. has a 1-year low of $24.21 and a 1-year high of $43.52. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $7.20 billion, a PE ratio of -194.24, a price-to-earnings-growth ratio of 2.13 and a beta of 0.98. The firm’s fifty day simple moving average is $41.81 and its 200-day simple moving average is $36.92.

American Healthcare REIT (NYSE:AHR) last posted its earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.40 by $0.02. The firm had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The business’s quarterly revenue was up 7.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.33 earnings per share. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. As a group, sell-side analysts anticipate that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio is -454.55%.

Insider Transactions at American Healthcare REIT

In other American Healthcare REIT news, EVP Mark E. Foster sold 3,850 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the sale, the executive vice president directly owned 59,100 shares in the company, valued at $2,475,699. This represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.92% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on AHR shares. Robert W. Baird started coverage on American Healthcare REIT in a research report on Friday, July 18th. They set an “outperform” rating and a $41.00 price objective for the company. KeyCorp increased their price objective on American Healthcare REIT from $40.00 to $43.00 and gave the company an “overweight” rating in a research report on Tuesday. Royal Bank Of Canada increased their price objective on American Healthcare REIT from $39.00 to $45.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. JMP Securities increased their price objective on American Healthcare REIT from $40.00 to $45.00 and gave the company a “market outperform” rating in a research report on Monday, August 11th. Finally, UBS Group started coverage on American Healthcare REIT in a research report on Friday, September 19th. They set a “buy” rating and a $51.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $44.44.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.